BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22849762)

  • 1. A double-blind randomised controlled trial of a natural oil-based emulsion (Moogoo Udder Cream®) containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer.
    Chan RJ; Keller J; Cheuk R; Blades R; Tripcony L; Keogh S
    Radiat Oncol; 2012 Jul; 7():121. PubMed ID: 22849762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.
    Chan RJ; Mann J; Tripcony L; Keller J; Cheuk R; Blades R; Keogh S; Poole C; Walsh C
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):756-64. PubMed ID: 25151541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials.
    Chan RJ; Webster J; Chung B; Marquart L; Ahmed M; Garantziotis S
    BMC Cancer; 2014 Jan; 14():53. PubMed ID: 24484999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blind, randomised controlled trial of StrataXRT® - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer.
    Chan RJ; Blades R; Jones L; Downer TR; Peet SC; Button E; Wyld D; McPhail S; Doolan M; Yates P
    Radiother Oncol; 2019 Oct; 139():72-78. PubMed ID: 31445838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial.
    Jensen JM; Gau T; Schultze J; Lemmnitz G; Fölster-Holst R; May T; Abels C; Proksch E
    Strahlenther Onkol; 2011 Jun; 187(6):378-84. PubMed ID: 21603988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Dermolina-Henna Cream with Mometasone Cream in Improving Radiodermatitis Among Patients with Breast Cancer: A Randomized Active-Control Double-Blind Clinical Trial.
    Pasalar M; Ahadi B; Mirzaei HR; Buentzel J; Mehri Ardestani M; Kamian S; Heydarirad G
    J Integr Complement Med; 2022 Nov; 28(11):895-903. PubMed ID: 36103288
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study.
    Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS
    Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Ectoin Versus Topical Dexpanthenol for Managing Acute Radiodermatitis Associated With Breast Cancer Radiotherapy: A Randomized Double-Blind Study.
    Abd Elazim NE; Awad SM; El-Naggar MS; Mohamed RH
    Dermatitis; 2023; 34(6):516-524. PubMed ID: 37792331
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design.
    Russell NS; van Werkhoven E; Schagen SB
    Support Care Cancer; 2017 Jan; 25(1):67-74. PubMed ID: 27554211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel of chamomile vs. urea cream to prevent acute radiation dermatitis in patients with head and neck cancer: a randomized controlled trial.
    Ferreira EB; Ciol MA; Vasques CI; Bontempo Pde S; Vieira NN; Silva LF; Avelino SR; Dos Santos MA; Dos Reis PE
    J Adv Nurs; 2016 Aug; 72(8):1926-34. PubMed ID: 27020698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions--results from a randomised blinded trial.
    Sharp L; Finnilä K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M
    Eur J Oncol Nurs; 2013 Aug; 17(4):429-35. PubMed ID: 23245940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
    Ulff E; Maroti M; Serup J; Falkmer U
    Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients: a controlled clinical trial (Alantel Trials).
    Jimenez-Garcia C; Perula-de Torres LA; Villegas-Becerril E; Muñoz-Gavilan JJ; Espinosa-Calvo M; Montes-Redondo G; Romero-Rodriguez E;
    Trials; 2024 Jan; 25(1):84. PubMed ID: 38273379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial.
    Wells M; Macmillan M; Raab G; MacBride S; Bell N; MacKinnon K; MacDougall H; Samuel L; Munro A
    Radiother Oncol; 2004 Nov; 73(2):153-62. PubMed ID: 15542162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
    Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
    Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
    Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
    Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
    Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
    Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.